MEMPHASYS LIMITED. — Investor Relations & Filings
Memphasys Limited is a biotechnology company specializing in the development of advanced cell separation and reproductive biotechnology solutions. The company's core technology platform utilizes proprietary membranes and electrophoresis to isolate high-quality cells from biological fluids. Its flagship product, the Felix™ system, is an automated device designed for the rapid separation of high-quality sperm from semen samples for use in human assisted reproductive technology (ART) procedures. This technology aims to improve clinical outcomes by selecting sperm with lower DNA fragmentation and higher motility compared to traditional centrifuge-based techniques. Beyond human fertility, the company applies its bio-separation expertise to animal health, including diagnostic tools for stallion fertility. Memphasys focuses on providing innovative solutions that enhance efficiency and success rates in the global reproductive health market.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Updated Securities Trading Policy 14 pages 542.2KB | 2026-05-03 | English | |
| Quarterly Activities/Appendix 4C Cash Flow Report 14 pages 1.3MB | 2026-04-16 | English | |
| Investor Presentation - April 2026 20 pages 1.8MB | 2026-04-06 | English | |
| Memphasys Investor Webinar 2 pages 275.0KB | 2026-04-01 | English | |
| MENA Orders Secured, Expanded & Operations Unaffected 4 pages 352.5KB | 2026-03-19 | English | |
| Appendix 4D - Half-year Financial Report - 31 December 2025 21 pages 1.1MB | 2026-02-26 | English |
Browse filings by year
20 years- 2026 20 filings
- 2025 90 filings
- 2024 100 filings
- 2023 43 filings
- 2022 53 filings
- 2021 47 filings
- 2020 33 filings
- 2019 62 filings
- 2018 52 filings
- 2017 62 filings
- 2016 35 filings
- 2015 51 filings
- 2014 48 filings
- 2013 65 filings
- 2012 68 filings
- 2011 80 filings
- 2010 87 filings
- 2009 81 filings
- 2008 56 filings
- 2007 48 filings
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Vaxil Bio Ltd.
Uses a proprietary Signal Peptide platform to develop immun…
|
VXL | CA | Professional, scientific and te… |
|
Vcanbio Cell & Gene Engineering Corp., Ltd
Focuses on stem cell bio-banking, genetic testing, and cell…
|
600645 | CN | Professional, scientific and te… |
|
VECTUS BIOSYSTEMS LIMITED
Develops therapeutics to reverse fibrosis and hypertension …
|
VBS | AU | Professional, scientific and te… |
|
Veradermics, Inc
Clinical-stage biopharmaceutical company developing medical…
|
MANE | US | Professional, scientific and te… |
|
Vera Therapeutics, Inc.
Clinical-stage biotech developing treatments for immunologi…
|
VERA | US | Professional, scientific and te… |
|
Veritas In Silico Inc.
A drug discovery company developing mRNA-targeting therapeu…
|
130A | JP | Professional, scientific and te… |
|
ViGenCell Inc.
Develops immune cell therapies to treat cancer and other in…
|
308080 | KR | Professional, scientific and te… |
|
Viking Therapeutics, Inc.
Clinical-stage biopharma developing therapies for metabolic…
|
VKTX | US | Professional, scientific and te… |
|
Vimta Labs Ltd.
Contract research and testing organization for life science…
|
VIMTALABS | IN | Professional, scientific and te… |
|
Vinext S.p.A.
Develops sustainable technology for the oenology and agri-f…
|
VNXT | IT | Professional, scientific and te… |
MEMPHASYS LIMITED. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/65314/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=65314 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=65314 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=65314 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 65314}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for MEMPHASYS LIMITED. (id: 65314)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.